NO962231L - Prolegemidler av paclitaxelderivater - Google Patents

Prolegemidler av paclitaxelderivater

Info

Publication number
NO962231L
NO962231L NO962231A NO962231A NO962231L NO 962231 L NO962231 L NO 962231L NO 962231 A NO962231 A NO 962231A NO 962231 A NO962231 A NO 962231A NO 962231 L NO962231 L NO 962231L
Authority
NO
Norway
Prior art keywords
drugs
paclitaxel derivatives
paclitaxel
derivatives
Prior art date
Application number
NO962231A
Other languages
English (en)
Other versions
NO962231D0 (no
NO315233B1 (no
Inventor
Paul M Scola
Dolatrai M Vyas
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO962231D0 publication Critical patent/NO962231D0/no
Publication of NO962231L publication Critical patent/NO962231L/no
Publication of NO315233B1 publication Critical patent/NO315233B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
NO19962231A 1995-06-06 1996-05-31 Prolegemidler av paclitaxelderivater NO315233B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (3)

Publication Number Publication Date
NO962231D0 NO962231D0 (no) 1996-05-31
NO962231L true NO962231L (no) 1996-12-09
NO315233B1 NO315233B1 (no) 2003-08-04

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962231A NO315233B1 (no) 1995-06-06 1996-05-31 Prolegemidler av paclitaxelderivater

Country Status (23)

Country Link
EP (1) EP0747385B1 (no)
JP (1) JPH08337589A (no)
KR (1) KR100375956B1 (no)
CN (1) CN1066151C (no)
AR (1) AR002756A1 (no)
AT (1) ATE222259T1 (no)
AU (1) AU695959B2 (no)
CA (1) CA2176191A1 (no)
CZ (1) CZ291516B6 (no)
DE (1) DE69622933T2 (no)
DK (1) DK0747385T3 (no)
ES (1) ES2181824T3 (no)
HU (1) HUP9601524A3 (no)
IL (1) IL118526A (no)
MX (1) MX9601994A (no)
NO (1) NO315233B1 (no)
NZ (1) NZ286723A (no)
PL (1) PL187883B1 (no)
PT (1) PT747385E (no)
RU (1) RU2162082C2 (no)
SG (1) SG72692A1 (no)
TW (1) TW354293B (no)
ZA (1) ZA964261B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
CN1261275A (zh) * 1997-05-27 2000-07-26 巴克·诺顿药物有限公司 给予病人口服紫杉烷类药物的方法和组合物
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
WO2000048606A1 (en) * 1999-02-18 2000-08-24 Oxigene, Inc. Compositions and methods for use in targeting vascular destruction
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
TR200102857T1 (tr) 2000-02-02 2002-06-21 Florida State University Research Foundation Inc. Antitümör ajanları olarak C7 karbonat ikameli taksanlar
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
JP4369237B2 (ja) * 2001-12-21 2009-11-18 エーザイ コーポレーション オブ ノース アメリカ アルコールおよびフェノールの水溶性ホスホノオキシメチル誘導体の調製法
EP1737444A4 (en) 2004-03-05 2008-05-21 Univ Florida State Res Found C7-LACTYLOXA-SUBSTITUTED TAXANE
US20090130163A1 (en) * 2005-02-18 2009-05-21 Abraxis Bio Scoence, Inc. Drugs With Improved Hydrophobicity For Incorporation in Medical Devices
ITMI20050614A1 (it) * 2005-04-12 2006-10-13 Indena Spa Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
RU2420239C1 (ru) * 2009-10-21 2011-06-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения злокачественных забрюшинных опухолей у детей и подростков
US20160024084A1 (en) 2013-03-15 2016-01-28 Concert Pharmaceuticals, Inc. Deuterated palbociclib
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
US20180318268A1 (en) * 2015-11-19 2018-11-08 Biohaven Pharmaceutical Holding Company Ltd. Amine prodrugs of pharmaceutical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
MX9308012A (es) * 1992-12-24 1994-08-31 Bristol Myers Squibb Co Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
AR002756A1 (es) 1998-04-29
EP0747385B1 (en) 2002-08-14
TW354293B (en) 1999-03-11
AU695959B2 (en) 1998-08-27
MX9601994A (es) 1997-08-30
CN1066151C (zh) 2001-05-23
KR970000222A (ko) 1997-01-21
HUP9601524A3 (en) 2000-03-28
CN1144805A (zh) 1997-03-12
PL314637A1 (en) 1996-12-09
HUP9601524A2 (en) 1997-05-28
NO962231D0 (no) 1996-05-31
NO315233B1 (no) 2003-08-04
SG72692A1 (en) 2000-05-23
NZ286723A (en) 1998-03-25
DE69622933T2 (de) 2003-04-24
DK0747385T3 (da) 2002-12-16
JPH08337589A (ja) 1996-12-24
RU2162082C2 (ru) 2001-01-20
IL118526A (en) 2001-05-20
HU9601524D0 (en) 1996-07-29
PL187883B1 (pl) 2004-10-29
ES2181824T3 (es) 2003-03-01
ATE222259T1 (de) 2002-08-15
PT747385E (pt) 2002-11-29
DE69622933D1 (de) 2002-09-19
IL118526A0 (en) 1996-10-16
EP0747385A1 (en) 1996-12-11
ZA964261B (en) 1997-11-27
AU5471896A (en) 1996-12-19
CZ291516B6 (cs) 2003-03-12
CZ156396A3 (en) 1996-12-11
CA2176191A1 (en) 1996-12-07
KR100375956B1 (ko) 2003-04-21

Similar Documents

Publication Publication Date Title
NO962231L (no) Prolegemidler av paclitaxelderivater
EP0948341A4 (en) DERIVATIVES OF PHOSPHOLIPIDE MEDICINES
NO974466D0 (no) Anvendelse av fumagillol og derivater derav for fremstilling av medikamenter mot tarminfeksjoner
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
NO995113D0 (no) Substituerte benzopyranderivater for behandling av inflammasjon
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
FI930491A7 (fi) Fosfono-oxi- och karbonatderivat av taxol
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
DE69628353D1 (de) Benzopyran enthaltende Verbindungen und deren Prodrugformen
NO982809D0 (no) Prolegemidler av tombin-inhibitorer
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
NO953244L (no) Derivater av cyklodepeptid PF 1022
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
DE69603269D1 (de) Derivate von inulin
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
EP0850057A4 (en) Pharmaceutical compounds
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO973455D0 (no) Dermatologisk anvendelse av Vitamin-D-derivater
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu
ATE224891T1 (de) Chromon-derivate
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
BR9609723A (pt) Derivados da tricetona
EP0804205A4 (en) 4-AZA-19-NORANDROSTANDERIVATE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application